Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Major Depressive Disorder with Psychotic Features
NCT00174603Phase 3Terminated
- Sponsor
- Rush University Medical Center
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine, sponsored by Rush University Medical Center. Started Aug 2005; status: terminated.
02
Drugs
quetiapine
Beyond the preview
Go deeper on NCT00174603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00174603.